US4120975A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of psychiatric conditions
Assignee: Fisons Ltd
•
Filing: 1977-09-08
•
Granted: 1978-10-17
•
Expires: 1997-09-08
Abstract
Abstract There is described a method of treatment of certain psychiatric conditions which method comprises administration of a compound of the formula I, ##STR1## or a therapeutically acceptacle salt, ester or amide thereof, (as active ingredient), to a patient having such a condition.
Inventors
- 👤 Thomas Samuel Campbell Orr
- 👤 Patrick John Kingsley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 09:29
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
64 words
A method of treatment of psychiatric conditions in mammals which method comprises administration of an effective amount of a compound of the formula I, ##STR3## or a therapeutically acceptable salt, alkyl C 1 to 10 ester, mono-alkyl C 1 to 10 amide, di-alkyl C 1 to 10 amide or an unsubstituted amide thereof, as active ingredient, to a patient suffering from such a condition.
Claim 2
Independent Claim
64 words
A method of treatment of psychiatric conditions in mammals which method comprises administration of an effective amount of a compound of the formula I, ##STR3## or a therapeutically acceptable salt, alkyl C 1 to 10 ester, mono-alkyl C 1 to 10 amide, di-alkyl C 1 to 10 amide or an unsubstituted amide thereof, as active ingredient, to a patient suffering from such a condition.
Claim 3
Dependent Claim
17 words
A method according to claim 1, wherein the active ingredient is the free acid of formula I.
Claim 4
Dependent Claim
13 words
A method according to claim 1, wherein the active ingredient is administered orally.
Claim 5
Dependent Claim
31 words
A method according to claim 1, wherein from 1 to 50 mg of active ingredient, measured as free compound of formula I, is administered from 1 to 4 times a day.
Claim 6
Dependent Claim
31 words
A method according to claim 4, wherein from 2 to 12 mg of active ingredient, measured as free compound of formula I, is administered from 1 to 4 times a day.
Claim 7
Dependent Claim
31 words
A method according to claim 5, wherein from 3 to 6 mg of active ingredient, measured as free compound of formula I, is administered from 1 to 4 times a day.
Claim 8
Dependent Claim
26 words
A method according to claim 1, wherein from 1 to 200 mg of active ingredient, measured as free compound of formula I, is administered per day.
Claim 9
Dependent Claim
28 words
A method according to claim 1, wherein the psychiatric condition to be treated is selected from alcoholism, depression, mania, thought disorders, hallucinations, schizophrenia, manic depression and behavioural problems.
Claim 10
Dependent Claim
18 words
A method according to claim 1, wherein the active ingredient is administered in the form of a tablet.
Claim 11
Dependent Claim
14 words
A method according to claim 1, wherein the active ingredient is administered before meals.
References Cited (Backward Citations)
US3484445A
Cited
US3952013A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-10-16 | 1982-04-17 | 1982-10-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-10-16 | 1986-04-17 | 1986-10-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-10-16 | 1990-04-17 | 1990-10-17 | $7700.00 | Window Closed / Lapsed |